<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>NOPR Collection: &lt;b&gt;[Pages 370-432]&lt;/b&gt;</title>
    <link>http://nopr.niscpr.res.in/handle/123456789/54444</link>
    <description>&lt;b&gt;[Pages 370-432]&lt;/b&gt;</description>
    <pubDate>Fri, 09 Oct 2026 06:10:54 GMT</pubDate>
    <dc:date>2026-10-09T06:10:54Z</dc:date>
    <item>
      <title>Repression of autophagy in diabetic cardiomyopathy via  RhoA/ROCK2 signaling pathways</title>
      <link>http://nopr.niscpr.res.in/handle/123456789/54452</link>
      <description>Title: Repression of autophagy in diabetic cardiomyopathy via  RhoA/ROCK2 signaling pathways
Authors: Fu, Cheng Yu; Fen, Guo Xiao
Abstract: Activated RhoA and ROCK is associated with many cardiovascular diseases (CVD) such as congestive heart failure (CHF), atherosclerosis and hypertension. However, the role of RhoA/ROCK2 signaling pathway in initiating diabetic cardiomyopathy (DCM) has not been fully elucidated. Here, we studied the role of RhoA/ROCK2 signaling pathway in induction of DCM through autophagy suppression in diabetic rat animal models. Broadly, we investigated the potential role and mechanism of diabetes induced myocardial dysfunction in rats. DCM was induced by injections of streptozocin (STZ) in experimental Wistar rats. The experimental rats were randomized to be treated with fasudil and lentivirus carrying the RhoA cDNA. Haemodynamic changes, assessment of cardiac weight index, histopathological examinations, cardiomyocyte autophagy and expression of RhoA and ROCK2 mRNAs were compared between groups. The expression of RhoA and ROCK mRNAs was found significantly increased in cardiac tissues compared with control group. The RhoA overexpression significantly decreased the values of left ventricular ejection fraction (LVEF), ±dp/dtmax and repressed autophagy. RhoA/ROCK2 signaling pathway repressed autophagy in diabetic cardiomyopathy indicating that it may serve as a potential therapeutic target for DCM treatment.
Page(s): 375-380</description>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://nopr.niscpr.res.in/handle/123456789/54452</guid>
      <dc:date>2020-06-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Development and evaluation of a novel herbal formula for tobacco cessation  in nicotine addicted rat model</title>
      <link>http://nopr.niscpr.res.in/handle/123456789/54451</link>
      <description>Title: Development and evaluation of a novel herbal formula for tobacco cessation  in nicotine addicted rat model
Authors: Gadhvi, KV; Rai, PD; Lavhale, MS; Mishra, SH
Abstract: Tobacco addiction is a major cause of disabilities and premature death. Numerous therapies for de-addiction are available; however, nicotine dependence and withdrawal symptoms pose problems for addicts. Here, we developed novel herbal formulations using natural plant parts and evaluated for de-addiction of nicotine. Parts of Withania somnifera (L.) Dunal, Avena sativa L., Cinnamomum cassia Blume, Acacia catechu (L.f.)Willd., Ocimum tenuiflorum L. and Glycyrrhiza glabra L. were formulated in three formulations containing alcohol extracts (AELF), aqueous extracts (WELF) and powdered herbs (PHLF). Swiss albino Wistar rats were addicted with nicotine 10 mg/kg/day for first five days and 20 mg/kg/day for next 10 days subcutaneously. Control rats were administered with 0.9% NaCl (Group VII) and addicted animals were treated with bupropion, 40 mg/kg, p.o. (Group I), rid-tobak, 200 mg/kg, p.o. (Group II), AELF, 200 mg/kg, p.o. (Group III), WELF, 200 mg/kg, p.o. (Group IV), PHLF, 200 mg/kg, p.o. (Group V), 0.5% sodium carboxymethyl cellulose, p.o. (Group VI) for 15 days. The animals were subjected to Y-maze test, swimming endurance test, behavioural studies on Day 0, 1, 6, 11 and on Day 16 after withdrawal of nicotine. On Day16, brain dopamine and serum cortisol levels were measured. Rats treated with AELF and PHLF showed significant improvement in behavioural parameters, increased brain dopamine level and decreased serum cortisol levels thus being a promising choice for tobacco cessation.
Page(s): 381-388</description>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://nopr.niscpr.res.in/handle/123456789/54451</guid>
      <dc:date>2020-06-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Antiproliferative effects of total alkaloid extract of roots of  Chassalia curviflora (Wall.) Thwaites on cancer cell lines</title>
      <link>http://nopr.niscpr.res.in/handle/123456789/54450</link>
      <description>Title: Antiproliferative effects of total alkaloid extract of roots of  Chassalia curviflora (Wall.) Thwaites on cancer cell lines
Authors: Rajeswari, Gopal G; Lakshmi, S; Jayakumaran, Nair A; Gangaprasad, A; Sudhakaran, PR; Muraleedharan, D; Nair, GM
Abstract: Chassalia curviflora is used in folklore medicines for treating several ailments and infections owing to its anti-inflammatory properties. Though the plant has been reported to possess anti-inflammatory antihepatotoxic and analgesic activities, its anticancer potential has not been studied so far. In the present study, we investigated the antiproliferative effects of the total alkaloids isolated from the roots of C. curviflora. The total alkaloid was validated by MTT assay in three cancer cell lines, such as liver cancer cell line-A549, breast cancer cell line-MCF-7 and ovarian cancer cell line -HeLa. Significant antiproliferative effect (IC50 value 3.59±0.14*** µg/mL) was observed in A549 cells, and was taken for further studies. Cell cycle analysis showed that the cells got arrested in sub G0 phase and annexin V-FITC assay revealed that 27.4% cells were in early apoptosis and 7% cells in late apoptosis. The study revealed that the total alkaloids of Chassalia curviflora roots possess significant antiproliferative and apoptotic activity.
Page(s): 389-395</description>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://nopr.niscpr.res.in/handle/123456789/54450</guid>
      <dc:date>2020-06-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Phytochemical analysis, antimicrobial, antioxidant and enzyme inhibitory activities of ethanolic extract of Centaurea solstitialis L. and its different fractions</title>
      <link>http://nopr.niscpr.res.in/handle/123456789/54449</link>
      <description>Title: Phytochemical analysis, antimicrobial, antioxidant and enzyme inhibitory activities of ethanolic extract of Centaurea solstitialis L. and its different fractions
Authors: Ahmad, Saeed; Saba, Sahar; Asif, Hafiz Muhammad
Abstract: Resistance to conventional antimicrobial regimes is one of the issues of concern in healthcare and it drives the need for development of new antimicrobial agents. Medicinal plants, as rich source of biochemical and bioactive compounds, serve as potential source for new drugs. Here, we evaluated the ethanolic extract of Centaurea solstitialis L. and its different fractions (n-hexane, choloroform and n-butanol soluble fraction) for antimicrobial, antioxidant and enzymes inhibitory activities. Antibacterial activity against two Gram-positive and three Gram-negative bacteria species were determined by using agar well diffusion and 96-wells microplate methods. Similarly, antifungal activity against two fungal strains was also evaluated by agar well diffusion method. Antioxidant activity analyzed by measuring the scavenging activity of DPPH radicals and acetylcholinesterase, butrylcholinesterase and chymotrypsin inhibitory activity was determined at 10 µg/mL and 1.0 mg/mL concentrations. Results revealed that the ethanolic extract of C. solstitialis and its different fractions possesses significant (P&lt;0.05) antibacterial activity and effective against fungi Aspergillus niger and Macrophomina phaseolina. Significant (P&lt;0.05) DPPH scavenging activity (88.52±0.23%) among all fractions was noted. n-Butanol fraction showed significant acetyl-cholinesterase (78.55±0.76%) and butrylcholinesterase inhibitory activity (78.1±0.41%) with IC50 values of 54.6±0.39 µg/mL and 211.9±0.15 µg/mL, respectively. Maximum chymotrypsin inhibition activity was shown by crude ethanolic extract (87.76±1.17) with IC50 value of 38.23±0.75 µg/mL. It is concluded that C. solstitialis extract and its fractions possess significant antimicrobial, antioxidant and enzyme inhibitory activity.
Page(s): 396-403</description>
      <pubDate>Mon, 01 Jun 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://nopr.niscpr.res.in/handle/123456789/54449</guid>
      <dc:date>2020-06-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

